4//SEC Filing
Munsie Jeffrey A 4
Accession 0001209191-23-009950
CIK 0001367920other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 8:49 AM ET
Size
5.5 KB
Accession
0001209191-23-009950
Insider Transaction Report
Form 4
Munsie Jeffrey A
Chief Legal Officer
Transactions
- Sale
Common Stock
2023-02-15$8.34/sh−3,762$31,375→ 88,049 total
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan entered into on June 28, 2022.
- [F2]These shares were sold to satisfy tax obligations associated with the vesting of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.33 to $8.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
Documents
Issuer
CONCERT PHARMACEUTICALS, INC.
CIK 0001367920
Entity typeother
Related Parties
1- filerCIK 0001703041
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 8:49 AM ET
- Size
- 5.5 KB